Public demand for emerging biomedical technologies is higher than ever. Patients, investors and philanthropic supporters find themselves in unfamiliar territory, now as consumers of cutting-edge medical options which require diligence and careful consideration. There are little direction and sound resources for the patient consumer to understand the what, where and who(?) regarding investments of time, money and risk in fields like regenerative medicine and stem cell therapies, age management medicine, nutrition and supplementation and genetic testing. The piece will introduce Dr. David Karli, who has had unique and intensive exposure to these emerging medical and scientific fields. Is tomorrow’s medicine here today? Is modern med-tech hope or hype?